Objectives: Opioids are the cornerstone therapy for the optimal pain management. Perioperative opioid infusion is accused of causing acute opioid tolerance, especially as the postoperative opioid requirement increases in time to provide efficient analgesia. It is debatable whether there is a difference between opioid agents regarding tolerance development. We aim to compare the effects of morphine, remifentanil and alfentanil when infused intravenously during the perioperative period. Methods: Sixty patients undergoing elective major abdominal surgery were randomized into four groups. The four groups obtained the following treatments: saline 5 cc iv bolus and 10 cc/h infusion for induction and maintenance in Group C, remifentanil infusion 0.25 μg/kg/min following 1μg/kg iv bolus in Group R, alfentanil infusion 0.50 μg/kg/min following 10 μg/ kg iv bolus in Group A, and morphine infusion 0.02 mg/kg/h after 0.1 mg/kg iv bolus in Group M. Meperidine 10 mg/cc iv patient-controlled analgesia was used postoperatively, and total meperidine consumptions were recorded. VAS scores and side effects were recorded during postoperative 48 hours. Results: VAS scores in Group M were found to be significantly lower than in Group C at the 1 st postoperative hour. Twentyfour hour total meperidine consumption in Group R and Group M were significantly lower than in Group C. No statistical difference was found between groups regarding the incidence of nausea and vomiting. Conclusion: Our study indicated that infusions of morphine, alfentanil and remifentanil administered to patients undergoing major abdominal surgery did not cause acute opioid tolerance. In contrast, infusion of morphine and remifentanil reduced postoperative opioid requirement.
Introduction
Opioids compose the main component of acute postoperative pain management. They are also widely used during the intraoperative period as they reduce the need for inhalational anesthetic agents. [1] However, perioperative opioid infusion is accused to result in acute opioid tolerance as the postoperative opioid requirement increases in time to provide efficient analgesia. It comes out as a decrease in drug efficacy.
Desensitization of antinociceptive system, which leads to the development of resistance against primary drug effect and sensitization of pronociceptive system, are blamed for this tolerance formation. [2] Although acute opioid tolerance has been well-identified for many years, the results obtained from clinical and experimental studies are still controversial. [3] [4] [5] [6] Aguado et al. [3] have reported that acute opioid tolerance develops in rats, and that can be prevented with the use of gabapentin. Nevertheless, another experimental study could not find any evidence in favor of acute opioid tolerance after short-term (1h) and long-term (4h) infusion of remifentanil. [4] The fact that perioperative remifentanil infusion causes acute opioid tolerance in children undergoing elective laparoscopic ureteroneocystostomy has been reported to be associated with the infusion dose. [5] In addition to the development of acute opioid tolerance, it is still a debatable topic whether there is a difference between opioid agents regarding tolerance development or not. [6] This prospective, randomized, placebo-controlled double-blind study aimed to compare the effects of morphine, remifentanil and alfentanil which were infused intravenously during perioperative period.
Materials and Methods:
Following the approval of the ethics committee and patients' written informed consents, 60 American Society of Anesthesiology (ASA) 1-2 patients, between the ages of 20-60 years, and undergoing elective major abdominal surgery, were recruited in the study. Exclusion criteria consisted of patient refusal, hypersensitivity to opioids, preoperative opioid use, complications during surgery, side effects of opioid therapy such as respiratory depression, severe nausea and vomiting, and itching. All patients received 0.015 mg/kg atropine sulphate and 0.07 mg/kg midazolam IM as a premedication 45 min before surgery. Anesthesia was induced with thiopental sodium 5 mg/kg and vecuronium 0.1 mg/kg iv and was maintained with 1 MAC desflurane and 70% nitrous oxide in oxygen. All patients received 1 g of intravenous paracetamol intraoperatively.
Patients were randomized into four groups by using opaque envelopes. The anesthetist was blind to the opioid solution infused during general anesthesia. The control group (Group C) was administered normal saline 5 cc bolus and 10 cc/h infusion for induction and maintenance respectively. The remifentanil group (Group R) was administered remifentanil 1µg/kg iv bolus for induction and 0.25 µg/kg/ min infusion for maintenance. The alfentanil group (Group A) was administered alfentanil 10 µg/kg iv bolus and 0.50 µg/kg/min infusion for induction and maintenance of anesthesia, respectively. The morphine group (Group M) received morphine 0.1 mg/kg iv bolus for induction and 0.02 mg/kg/h infusion for maintenance. During the surgery, the opioid infusion rate was kept constant and we changed the desflurane concentration if necessary. The infusions were terminated at the beginning of the closure of the skin incision.
Every half hour during the operation desflurane concentrations were recorded. Total opioid consumption and the time of recovery were recorded at the end of the surgery. Recovery time is described as the time between the termination of inhalational anesthetic agents and the time patients obey the commands.
In the recovery room for postoperative analgesia, meperidine 1 mg/kg iv was administered to provide a Visual Analogue Scale (VAS) ≤30, and meperidine (10 mg/cc) iv patient-controlled analgesia (PCA) was started with a bolus dose of 1.5 cc and a lockout time of 8 min. VAS scores and side effects (nausea, vomiting, and itching, respiratory depression) were recorded at postoperative 1, 2, 4, 8, 12, 16, 24, 36 and 48th hours. Meperidine consumptions were noted in the postoperative first 48 hours. The primary outcome variable was the consumption of meperidine in the postoperative period. To dem-onstrate a 25% difference in initial 48-h meperidine consumption, we estimated that 15 patients per group would be required for α=0.05 and β=0.2 (power 80%). All statistical analyses were performed using SPSS (Statistical Package for Social Sciences) for Windows 10.0. In comparison of descriptive statistical methods (average, standard deviation) and quantitative data, we tested normal distributed data with one-way ANOVA test and the Student t test. We analyzed non-normal distributed data with Kruskal Wallis and Mann-Whitney U tests. Quantitative data were compared using Chi-Square test. A p value <0.05 was considered as statistically significant.
Results
No statistical difference was found between the groups regarding the demographical data and the duration of the surgery (p>0.05) ( Table 1 ). There was no statistical difference inside the groups regarding the preoperative desflurane concentrations (p>0.05). There was a statistically significant decrease of desflurane concentration in Group R at 15 th , 90 th and 120 th min compared to Group C and Group M and in Group A after 30th min compared to Group C and Group M (p<0.05) ( Table 2) .
Total opioids infused during perioperative period were as follows: 1.75±0.6 mg remifentanil in No statistical difference was found between groups regarding the incidence of nausea and vomiting (p>0.05) ( Table 5) . No other side effect was observed in patients other than nausea and vomiting.
Discussion
It was found in the current study that perioperative infusion of alfentanil, remifentanil and morphine did not lead to any increase in postoperative opioid requirement. Besides, infusion of morphine and remifentanil reduced the postoperative opioid requirement.
In the presence of acute tolerance, the required dose of a pharmacological agent increase to sustain its therapeutic effect. It is widely accepted that chronic opioid therapy is associated with the development of pharmacological tolerance. Nonetheless, acute VAS scores of Group M were found to be significantly lower than Group C at the 1 st hour (p<0.05). There was not a significant difference between groups at other measurement times (p>0.05) ( Table 3) . No difference was found between groups regarding the required loading dose of meperidine in the recovery unit (p>0.05) ( Table 4) . PCA meperidine consumption of Group R was lower compared to Group C after 24 th hour. Twenty four-hour total meperidine consumptions of Group R and Group M were significantly lower than Group C (p<0.05) ( Table 4) . tolerance development after short-time infusion is a debatable issue. Acute opioid tolerance was indicated in several experimental studies. [3, 7, 8] Although acute opioid tolerance was concluded to be observed in studies including healthy subjects and patients receiving high dose opioids during anesthesia, its presence is still controversial. [9, 10] Regarding the development of opioid tolerance, there are great differences between the results of the studies employing animal models and the studies including patients with pain. [11] [12] [13] While a study carried out administering 8 h morphine infusion to dogs and mice showed that the analgesic effect of morphine potently decreased, [14, 15] another rat study reported that prolonged remifentanil infusion did not cause acute analgesic tolerance.
[4] Schraag et al. [16] reported that neither alfentanil infusion given to 51 patients undergoing cardiac surgery nor remifentanil infusion administered to 30 patients undergoing orthopedic surgery led to the development of opioid tolerance. These contradictory results may suggest that the methods used for pain assessment are different for humans and animals. The assessment method used for humans is based on the principle that pain is expressed by the patient. When the degree of pain in animals are evaluated, pain behaviors are observed and pain assessment is indirectly analyzed according to these behaviors. As Mogil and Crager [17] indicated, assessing opioid analgesic tolerance on animal models may not produce reliable results because of the fact that pain behaviors include not only the nociceptive component but also the psychomotor component. In light of these results, our study has an advantage over other studies regarding precise assessment of acute opioid tolerance as our study examined the patients with postoperative pain.
Both the study subjects (whether the study is carried out on animals or humans) and the pain characteristics (whether it is clinical pain or experimental pain) have a role in obtaining different results. Vinik and Kissin [18] administered remifentanil infusion on 13 volunteers having experimentally created pain and indicated that these patients quickly developed tolerance against analgesia. Different pain modalities are created with experimental pain models. They ensure the standardization of painful stimulants; however, the pain is different from the clinical pain. In order to eliminate the difference mentioned above, in their study Ho et al. [19] performed abdominal surgery on rats, and thus, generated clinical pain. In this way, they indicated that postoperative pain prevented the development of opioid tolerance. However, it is not known exactly how surgical pain prevented acute opioid tolerance. The activation of the hypothalamic-pituitary-adrenal axis with stress, direct effect of ACTH or corticosteroids may be suggested to reduce the effect of the formation of acute morphine tolerance. [20] [21] [22] Considering these results and the fact that our study recruited the patients having clinical pain after surgery, it can be claimed that our study is more advantageous than other studies regarding precise assessment of acute opioid tolerance.
Because of various methods used in the assessment of analgesia and in drug administration, opioid tolerance may develop in different ways. [23] For instance, in a study examining intrinsic effects of opioid tolerance for different dose regimes it was found that continuous infusion led to opioid tolerance development in a completely different way as compared to intermittent infusion. [24] Also, the wide range of opioid application including acute/ chronic, spinal/supraspinal, and bolus injection/infusion plays a role in the occurrence of disparities in tolerance development. [24] [25] [26] There are publications showing the fact that opioid infusion facilitates the development of acute opioid tolerance. [10, 27] However, in a study by Kissin et al. [28] a group of rats was administered a single dose sc morphine while the other group was given morphine infusion, and both groups developed acute opioid tolerance after the administration. On the other hand, continuous morphine infusion has been reported to cause higher rate of opioid tolerance compared to intermittent infusion and single-dose of morphine. [29, 30] Although the degree of opioid tolerance is not related to the potency of the opioid, [31] formation rate depends upon the pharmacokinetics and pharmacodynamics of the opioid. [23] It was observed that particularly short-acting opioids develop tolerance. Tolerance development is more rapid especially when the short-acting opioids are used. Also, the short-acting opioids remifentanil and alfentanil are to patients undergoing major abdominal surgery did not cause acute opioid tolerance. In contrast, infusion of morphine and remifentanil reduced the postoperative opioid requirement. suggested to rapidly cause opioid tolerance. [32, 33] Alfentanil provides the balanced blood concentration in a shorter time in comparison to all other opioids used as infusion. However, we did not find any difference between the opioids used in the study regarding tolerance formation.
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Another factor that influences the formation and degree of tolerance is the dose of opioids. As opioid tolerance is related to pharmacodynamics, dependence on opioid dose is not surprising. [34] It was proposed that when high-dose of opioid was used, acute opioid tolerance developed more rapidly. [8] Chia et al. [35] compared the effects of low-dose (1 µgr/kg) and high-dose (15 µgr/kg) of fentanil on acute opioid tolerance in patients undergoing total abdominal hysterectomy. In that study, they indicated that postoperative opioid requirement was higher in the group receiving high-dose fentanil. In addition, a study conducted by Marshall et al. [36] reported that patients who were administered high-dose morphine infusion required more opioid in the postoperative period. Similarly, Joly et al. [37] indicated that postoperative pain scores were higher in patients undergoing colorectal-surgery and received high-dose remifentanil. Another study showed that approximately 3-h infusion of remifentanil caused acute tolerance in children. [5] However, it was reported that this effect occurred with the doses of 0.6-0.9 mcg/kg/min, and patients receiving 0.3 mcg/kg/min remifentanil infusion did not develop tolerance.
In the current study, we compared the groups receiving infusions of morphine, remifentanil and alfentanil with the control group and with one another. We used equivalant doses of opioids which are different in terms of potency and action time. We employed the visual analog scale in order to provide the most objective method for the assessment of postoperative pain levels, and determined the postoperative opioid requirement using the PCA method. None of the groups developed opioid tolerance in the postoperative period. In contrast, opioid consumption was found to be significantly lower especially in the morphine group as compared to the control group.
In conclusion, our study indicated that infusions of morphine, alfentanil and remifentanil administered
